Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Auteur de référence en rhumatologie
20 articles scientifiques publiés — un praticien à la pointe de la recherche
Disponibilité géographique
7 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
73.2 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
IMAGERIE MEDICALE 91
159 RUE PDT FRANCOIS MITTERRAND, 91160 LONGJUMEAU
IMAGERIE MEDICALE 91
HOPITAL PRIVE D'ATHIS MONS 38 AVENUE JULES VALLES, 91200 ATHIS MONS
IMAGERIE MEDICALE 91
CENTRE DE RADIOLOGIE 12 RUE DU CLOS, 91130 RIS ORANGIS
IMAGERIE MEDICALE 91
101 AV STALINGRAD, 91120 PALAISEAU
IMAGERIE MEDICALE 91
1 RUE DE LA CLAIRIERE, 91000 EVRY
IRM ORSAY GARE
4 PL DU GENERALE LECLERC, 91400 ORSAY
IMAGERIE MEDICALE 91
42 RUE JEAN COCTEAU, 91490 MILLY LA FORET
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Gut · 2007
Background/Aims: Whether a life-long gluten-free diet (GFD) is necessary in all children with diagnosed coeliac disease (CD) remains debated. To address this question, a retrospective analysis of the clinical and biological status of adult coeliac patients diagnosed in childhood, who remained on a normal diet after gluten challenge and were clinically silent, was carried out. Methods: Patients aged 18–65 years with CD diagnosed in childhood were included. Clinical status, gluten intake, biological parameters of malabsorption, bone mineral density, human leucocyte antigen (HLA) genotype, serological markers of CD, and histological and immunohistochemical parameters in duodenal biopsies were recorded. Results: Sixty-one patients had resumed a normal diet and were asymptomatic. Forty-eight showed different degrees of villous atrophy (silent CD), while 13 had no detectable atrophy (latent CD) on duodenal biopsies. Latent CD patients had significantly less osteopenia/osteoporosis (1/9 (11%) vs 23/33 (70%), p<0.001)), and lower T cell receptor (TCR) αβ+ intraepithelial T cell counts (38±20 vs 55±15, p<0.01) than silent CD patients. The mean age at diagnosis and first GFD was lower in latent than in silent patients (14.4±5 vs 40.1±47 months, p<0.05). Latent patients did not differ significantly from the seven control patients on a long-term GFD, except for a higher frequency of CD-specific serum antibodies. However, two latent patients relapsed clinically and histologically during subsequent follow-up. Conclusions: Long-term latency developed in about 20% of CD patients who remained symptom free after gluten reintroduction. This latency can be transient and thus a regular follow-up is mandatory. In silent patients, the increased risk of osteoporosis substantiates the need for a GFD.
Pediatric blood & cancer · 2014
BackgroundThis retrospective multicenter study assessed the clinical, radiological and pathological presentation, treatment and outcome of 26 patients with Ewing‐like sarcoma harboring BCOR‐CCNB3 gene fusion transcript. Tumor samples had been collected between 1994 and April 2012.ProcedureEligibility criteria included assessment of a BCOR‐CCNB3 transcript‐positive tumor after molecular analysis and availability of minimal clinical and pathological data. Radiological data were also retrieved when possible. Data were analyzed by descriptive statistics and methods for survival analysis.ResultsMedian age at diagnosis was 13.1 years (5.9 to 25.6 years). Most patients (24/26) had localized tumors. All tumors but five were localized to bone. CCNB3 immunochemistry showed strong nuclear staining on all samples. No specific radiological features were found. Most patients received chemotherapy (15 according to protocols designed for Ewing tumors), before and/or after local treatment (surgery and/or radiotherapy, with 46.2% receiving both). Local and metastatic relapses were of poor prognosis. Induction chemotherapy and treatment according to an Ewing protocol might influence survival for patients with localized tumors. Sixteen patients are alive in complete remission with a median follow‐up of 86 months. Five year overall survival and disease‐free survival were respectively 76.5% (95% CI, 58%–95%) and 67.9% (95% CI, 48%–88%).ConclusionsBCOR‐CCNB3 transcript‐positive Ewing‐like sarcoma diagnosis should be discussed for a transcript‐negative small round cell sarcoma in a child, adolescent or young adult patient. Diagnosis needs to be stated through CCNB3 immunochemistry or transcript identification. The exquisite chemosensitivity of these tumors should encourage the use of polychemotherapy for appropriate care, associated with best local tumor control. Pediatr Blood Cancer 2014;61:2191–2198. © 2014 Wiley Periodicals, Inc.
Gastroenterology · 2024
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Pediatric blood & cancer · 2022 · Journal Article
Irtan S, Donadieu J, Pacquement H, Tabone MD, et al.
Pediatric radiology · 2018 · Letter
Pariente D, Franchi-Abella S, Cellier C, Branchereau S, et al.
Journal of pediatric hematology/oncology · 2015 · Case Reports
Sudour-Bonnange H, Leblond P, Cellier C, Vinchon M, et al.
Clinical & experimental ophthalmology · 2015 · Journal Article
Boutroux H, Levy C, Mosseri V, Desjardins L, et al.
Pediatric blood & cancer · 2014 · Journal Article
Cohen-Gogo S, Cellier C, Coindre JM, Mosseri V, et al.
Journal of pediatric hematology/oncology · 2014 · Journal Article
Boutroux H, Cellier C, Mosseri V, Helfre S, et al.
Journal of pediatric hematology/oncology · 2014 · Journal Article
Kerouanton A, Jimenez I, Cellier C, Laurence V, et al.
Pediatric radiology · 2012 · Case Reports
Beurdeley M, Cellier C, Lemoine F, Dacher JN, et al.
Pediatric radiology · 2011 · Case Reports
Vivier PH, Liard A, Beurdeley M, Brasseur-Daudruy M, et al.
Pediatric radiology · 2010 · Case Reports
Grzegorczyk V, Brasseur-Daudruy M, Labadie G, Cellier C, et al.
Gastroenterology · 2024 · Journal Article
Zingone F, Bai JC, Cellier C, Ludvigsson JF
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... · 2020 · Clinical Trial
Gauthé M, Breton M, Jehanno N, Cellier C, et al.
BMC medical informatics and decision making · 2017 · Journal Article
Escudié JB, Rance B, Malamut G, Khater S, et al.
European journal of human genetics : EJHG · 2018 · Case Reports
Masliah-Planchon J, Lévy D, Héron D, Giuliano F, et al.
Neuroradiology · 2018 · Journal Article
Duron L, Sadones F, Thiesse P, Cellier C, et al.
Diagnostic cytopathology · 2017 · Evaluation Study
Vlajnic T, Brisse HJ, Aerts I, Fréneaux P, et al.
Bulletin du cancer · 2014 · English Abstract
Levy D, Aerts I, Michon J, Lumbroso-Le Rouic L, et al.
La Revue de medecine interne · 2010 · English Abstract
Malamut G, Cellier C
Gut · 2007 · Journal Article
Matysiak-Budnik T, Malamut G, de Serre NP, Grosdidier E, et al.
La Revue du praticien · 2001 · English Abstract
Cellier C, Grosdidier E